statistiche ricercatore

Continente	#
NA - Nord America	1.349
EU - Europa	539
AS - Asia	537
SA - Sud America	118
AF - Africa	14
OC - Oceania	6
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.564

Nazione	#
US - Stati Uniti d'America	1.332
SG - Singapore	180
GB - Regno Unito	156
CN - Cina	136
DE - Germania	119
BR - Brasile	84
HK - Hong Kong	67
FI - Finlandia	64
VN - Vietnam	63
SE - Svezia	50
IT - Italia	48
UA - Ucraina	26
RU - Federazione Russa	19
TR - Turchia	18
FR - Francia	17
AR - Argentina	13
BG - Bulgaria	11
IN - India	11
ID - Indonesia	9
BD - Bangladesh	8
CA - Canada	8
KR - Corea	8
NL - Olanda	7
AU - Australia	6
BE - Belgio	6
CO - Colombia	6
ZA - Sudafrica	6
PK - Pakistan	5
VE - Venezuela	5
AE - Emirati Arabi Uniti	4
CL - Cile	4
ES - Italia	4
IQ - Iraq	4
PH - Filippine	4
SA - Arabia Saudita	4
IE - Irlanda	3
JP - Giappone	3
MX - Messico	3
NP - Nepal	3
AZ - Azerbaigian	2
EC - Ecuador	2
JO - Giordania	2
MA - Marocco	2
PA - Panama	2
PL - Polonia	2
PR - Porto Rico	2
PY - Paraguay	2
AO - Angola	1
AT - Austria	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
HU - Ungheria	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
KZ - Kazakistan	1
LT - Lituania	1
MK - Macedonia	1
MU - Mauritius	1
MY - Malesia	1
PE - Perù	1
QA - Qatar	1
RO - Romania	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
Totale	2.564

Nome	#
Structural models and binding site prediction of the C-terminal domain of human Hsp90: a new target for anticancer drugs	420
A computational workflow for the design of irreversible inhibitors of protein kinases	311
BEAR, a novel virtual screening methodology for drug discovery	302
Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening	286
Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors	278
Exploring the binding site of C-terminal Hsp90 inhibitors	265
In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation	261
Design and discovery of plasmepsin inhibitors using an automated workflow on large scale grids	248
Improving enrichment and hit rate in virtual screening	205
Totale	2.576

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	56	0	0	0	0	0	0	0	0	0	36	6	14
2021/2022	219	10	43	22	7	1	3	17	12	19	22	47	16
2022/2023	188	28	30	7	19	17	23	1	18	24	2	15	4
2023/2024	109	2	4	6	3	22	13	9	31	0	0	9	10
2024/2025	507	4	6	9	27	77	76	59	72	59	17	35	66
2025/2026	724	56	29	56	71	126	59	91	40	81	115	0	0
Totale													2.576